Organisation paid for research Program year 2021 Source: CMS Open Payments

Prevea Clinic Inc

Neither a doctor nor a teaching hospital

Research payments

$219,369

65 payments

Through program year 2021, Prevea Clinic Inc is reported as receiving $219,369 in research payments, across 65 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$13,861	9
2020	Research	$67,521	20
2019	Research	$137,987	36

Breakdown

Who paid Research payments · program years 2019–2021

Medtronic Vascular, Inc. $90,625 19 payments
Pfizer Inc. $58,159 11 payments
Takeda Pharmaceuticals U.S.A., Inc. $22,550 4 payments
Eli Lilly and Company $13,539 2 payments
Boston Scientific Corporation $12,141 19 payments
PTC Therapeutics, Inc. $11,953 4 payments
Medtronic, Inc. $10,403 6 payments

Studies the money was for Research payments · program years 2019–2021

Resolute Onyx PAS $93,030 21 payments
A Phase 3 Randomized Doubleblind Placebocontrolled 26Week Multicenter Study With A 78Week Extension to Evaluate the Efficacy and Safety of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Metformin Mo $58,159 11 payments
The Global Multiple Myeloma Registry- A Global, Prospective, Observational Study of Patient Outcomes Following Treatment of Multiple Myeloma INSIGHT $22,550 4 payments
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus $13,539 2 payments
Longevity Study $12,141 19 payments
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension $11,953 4 payments
Resolute Onyx 2.0 mm $5,180 3 payments
Resolute Integrity US $2,818 1 payment

What the money was spent on Research payments · program years 2019–2021

Other $22,550 4 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.